Search - tctmd.com

Displaying 221 - 231 of 231

Sort: Relevancy | Date

News Daily News

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

September 27, 2012

Presentation

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Presenter: S.R. Gangireddy

September 26, 2012

News Daily News

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

July 31, 2012

Presentation

Does the Left Atrial Appendage Morphology Correlate with Stroke Risk in Patients with A-fib?

Presenter: L. Di Biase

July 30, 2012

Presentation TVT 2012

The Evolving Standard of Care: Oral Antithrombotic Agents for Stroke Prevention in Atrial Fibrillation

Presenter: Gregg Stone

June 05, 2012

Presentation TVT 2012

The Evolving Standard of Care: Atrial Fibrillation Ablation

Presenter: Shephal Doshi

June 05, 2012

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

Presentation

Watchman LAA Closure in A-fib Patients with Contraindication to Oral Anticoagulation

Presenter: Vivek Y. Reddy

May 30, 2012

News Daily News

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

Jason Kahn

March 05, 2012

Presentation

The Clinical Impact of Incomplete LAA Closure With the Watchman Device in Patients With A-fib

Presenter: J. Viles-Gonzalez

February 26, 2012

News Daily News

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Caitlin E. Cox

January 20, 2011

Advertisement

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

Does the Left Atrial Appendage Morphology Correlate with Stroke Risk in Patients with A-fib?

The Evolving Standard of Care: Oral Antithrombotic Agents for Stroke Prevention in Atrial Fibrillation

The Evolving Standard of Care: Atrial Fibrillation Ablation

Watchman Works Just as Well Without Warfarin-Protected Transition

Watchman LAA Closure in A-fib Patients with Contraindication to Oral Anticoagulation

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

The Clinical Impact of Incomplete LAA Closure With the Watchman Device in Patients With A-fib

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content